Dermatofibroma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (13 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dermatofibroma}} | {{Dermatofibroma}} | ||
{{CMG}} | {{CMG}}, {{AE}}{{Homa}} | ||
==Overview== | ==Overview== | ||
[[Surgery]] is the first-line treatment option for [[patients]] with dermatofibroma. Surgery is usually used for patients with either [[Cosmetics|cosmetic]] reasons, [[symptomatic]] [[lesions]], uncertain [[diagnosis]] and aggressive subtypes. Complete [[excision]] which is involved [[subcutaneous fat]] incorporated with 1-3 mm margin based on the location of [[Lesions|lesion]] is recommended. [[Cryosurgery]] or [[superficial]] shaving as a purpose of cosmetic or controlling [[symptoms]] are accompanied by increasing risk of recurrence. | |||
[[Category: | ==Indications== | ||
*[[Surgery]] is the first-line treatment option for [[patients]] with dermatofibroma.[[Surgery]] is usually used for [[Patient|patients]] with either:<ref name="KimKim2015">{{cite journal|last1=Kim|first1=Hee Joo|last2=Kim|first2=Il-Hwan|title=A 3-mm Margin Completely Removes Dermatofibromas|journal=Dermatologic Surgery|volume=41|issue=2|year=2015|pages=283–286|issn=1076-0512|doi=10.1097/DSS.0000000000000235}}</ref> | |||
**[[Cosmetics|Cosmetic]] reasons | |||
**[[Symptomatic]] [[lesions]] (like [[bleeding]]) | |||
**Uncertain [[diagnosis]] | |||
**Aggressive subtypes ( like aneurysmal dermatofibroma) | |||
==Surgery== | |||
*Complete [[excision]] which is involved [[subcutaneous fat]] incorporated with 1-3 mm margin based on the location of [[Lesions|lesion]] is recommended. <ref name="KimKim2015">{{cite journal|last1=Kim|first1=Hee Joo|last2=Kim|first2=Il-Hwan|title=A 3-mm Margin Completely Removes Dermatofibromas|journal=Dermatologic Surgery|volume=41|issue=2|year=2015|pages=283–286|issn=1076-0512|doi=10.1097/DSS.0000000000000235}}</ref><ref name="EstelaRico2014">{{cite journal|last1=Estela|first1=J.R.|last2=Rico|first2=M.T.|last3=Pérez|first3=A.|last4=Unamuno|first4=B.|last5=Garcías|first5=J.|last6=Cubells|first6=L.|last7=Alegre|first7=V.|title=Dermatofibromas faciales: estudio clínico-patológico de 20 casos|journal=Actas Dermo-Sifiliográficas|volume=105|issue=2|year=2014|pages=172–177|issn=00017310|doi=10.1016/j.ad.2013.10.002}}</ref><ref>{{Cite journal | |||
| author = [[T. Mentzel]], [[H. Kutzner]], [[A. Rutten]] & [[H. Hugel]] | |||
| title = Benign fibrous histiocytoma (dermatofibroma) of the face: clinicopathologic and immunohistochemical study of 34 cases associated with an aggressive clinical course | |||
| journal = [[The American Journal of dermatopathology]] | |||
| volume = 23 | |||
| issue = 5 | |||
| pages = 419–426 | |||
| year = 2001 | |||
| month = | |||
| pmid = 11801774 | |||
|url=|first=|date=|via=}}</ref> | |||
*[[Cryosurgery]] or [[superficial]] shaving as a purpose of cosmetic or controlling [[symptoms]] are accompanied by increasing risk of recurrence.<ref>{{Cite journal | |||
| author = [[W. F. Spiller]] & [[R. F. Spiller]] | |||
| title = Cryosurgery in dermatologic office practice: special reference to dermatofibroma and mucous cyst of the lip | |||
| journal = [[Southern medical journal]] | |||
| volume = 68 | |||
| issue = 2 | |||
| pages = 157–160 | |||
| year = 1975 | |||
| month = | |||
| pmid = 1118748 | |||
|url=|first=|date=|via=}}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
| |||
[[Category:Medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category: | [[Category:Surgery]] | ||
Latest revision as of 21:18, 29 July 2020
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma surgery On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma surgery |
|
Risk calculators and risk factors for Dermatofibroma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Surgery is the first-line treatment option for patients with dermatofibroma. Surgery is usually used for patients with either cosmetic reasons, symptomatic lesions, uncertain diagnosis and aggressive subtypes. Complete excision which is involved subcutaneous fat incorporated with 1-3 mm margin based on the location of lesion is recommended. Cryosurgery or superficial shaving as a purpose of cosmetic or controlling symptoms are accompanied by increasing risk of recurrence.
Indications
- Surgery is the first-line treatment option for patients with dermatofibroma.Surgery is usually used for patients with either:[1]
- Cosmetic reasons
- Symptomatic lesions (like bleeding)
- Uncertain diagnosis
- Aggressive subtypes ( like aneurysmal dermatofibroma)
Surgery
- Complete excision which is involved subcutaneous fat incorporated with 1-3 mm margin based on the location of lesion is recommended. [1][2][3]
- Cryosurgery or superficial shaving as a purpose of cosmetic or controlling symptoms are accompanied by increasing risk of recurrence.[4]
References
- ↑ 1.0 1.1 Kim, Hee Joo; Kim, Il-Hwan (2015). "A 3-mm Margin Completely Removes Dermatofibromas". Dermatologic Surgery. 41 (2): 283–286. doi:10.1097/DSS.0000000000000235. ISSN 1076-0512.
- ↑ Estela, J.R.; Rico, M.T.; Pérez, A.; Unamuno, B.; Garcías, J.; Cubells, L.; Alegre, V. (2014). "Dermatofibromas faciales: estudio clínico-patológico de 20 casos". Actas Dermo-Sifiliográficas. 105 (2): 172–177. doi:10.1016/j.ad.2013.10.002. ISSN 0001-7310.
- ↑ T. Mentzel, H. Kutzner, A. Rutten & H. Hugel (2001). "Benign fibrous histiocytoma (dermatofibroma) of the face: clinicopathologic and immunohistochemical study of 34 cases associated with an aggressive clinical course". The American Journal of dermatopathology. 23 (5): 419–426. PMID 11801774.
- ↑ W. F. Spiller & R. F. Spiller (1975). "Cryosurgery in dermatologic office practice: special reference to dermatofibroma and mucous cyst of the lip". Southern medical journal. 68 (2): 157–160. PMID 1118748.